Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

GlobeNewswire
02/12

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.

Conference Call Information

To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.

Event Date: Wednesday, February 25, 2026
Time: 1:30 PM Pacific Time

Participant Registration: https://register-conf.media-server.com/register/BIb4506be22c484ba7a7767032cba20986

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
IR@Carlsmed.com

Media

LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10